Quantcast

Latest Medicago Stories

2011-03-15 06:00:00

APPROVED FOR PUBLIC RELEASE, DISTRIBUTION UNLIMITED RALEIGH AND QUEBEC CITY, March 15 /PRNewswire-FirstCall/ - Medicago USA Inc., a wholly owned subsidiary of Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the second milestone payment of US$3.8 million from the Defense Advanced Research Projects Agency...

2011-03-14 15:06:00

QUEBEC CITY, March 14 /PRNewswire/ - Medicago Inc. (TSX: MDG) a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that Mr. Pierre Labbe, Chief Financial Officer will present a corporate update at the 23(rd) Annual Roth OC Growth Stock Conference on Tuesday, March 15, 2011 at 8:00 a.m. Pacific Time at The Ritz Carlton Laguna Niguel in Dana Point,...

2011-02-15 06:00:00

QUEBEC CITY, Feb. 15 /PRNewswire-FirstCall/ - Medicago Inc. (TSX: MDG) a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that Ms. Nathalie Landry, Vice President of Product Development, is invited to present at the 7(th) WHO meeting on evaluation of pandemic influenza prototype vaccines in clinical trials. The conference is being held at the World...

2011-02-10 07:00:00

QUEBEC CITY, Feb. 10 /PRNewswire/ - Medicago Inc. (TSX: MDG) a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that Mr. Andy Sheldon, President and Chief Executive Officer of Medicago will be presenting at the 13th Annual BIO CEO & Investor Conference. The conference is being held at the Waldorf Astoria in New York City from February 14(th)-15(th),...

2011-01-27 15:48:00

WEST SALEM, Wis., Jan. 27, 2011 /PRNewswire/ -- Today, the U.S. Department of Agriculture announced the deregulation of Roundup Ready® Alfalfa (RRA) without conditions. This was the final step in an extensive environmental review process undertaken by the USDA that took 46 months to complete. With the return of RRA to the U.S. market, alfalfa growers will once again have the option to use this safe, beneficial technology. Some of the benefits of RRA include a more...

2010-12-16 16:29:00

WEST SALEM, Wisc., Dec. 16, 2010 /PRNewswire/ -- Today, the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) announced that the long-awaited Environmental Impact Statement (EIS) on Roundup Ready® Alfalfa (RRA) has been published. An electronic copy of the document can be found at: http://www.aphis.usda.gov/biotechnology/downloads/alfalfa/gt_alfalfa%20_feis.pdf "Publication of the final EIS marks an important, critical step to...

2010-12-08 08:14:00

QUEBEC CITY, Dec. 8 /PRNewswire-FirstCall/ - Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has engaged Paul Kirkconnell, a seasoned advisor to the pharmaceutical and vaccine industry, as a consultant on business development matters. Paul Kirkconnell, founder of P-A-K Limited, provides biopharmaceutical companies with...

2010-11-26 07:31:00

QUEBEC CITY, Nov. 26 /PRNewswire/ - Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced an extension to its partnering agreement of July 2009 with Genopole(R). Medicago and Genopole(R) will also work towards the creation a laboratory for research on vaccine and antibody targets of interest for France in terms of public health...

2010-11-12 16:02:00

QUEBEC CITY, Nov. 12 /PRNewswire-FirstCall/ - Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced its operational and financial results for the third quarter ended September 30, 2010. The Company's financial statements and management report are available at www.sedar.com and at www.medicago.com. "There were several key developments...

2010-11-10 06:00:00

QUEBEC CITY, Nov. 10 /PRNewswire/ - Medicago USA Inc., a wholly owned subsidiary of Medicago Inc. (TSX: MDG) a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), announced today that it has been awarded US$244,279 in funding under the Internal Revenue Service's Qualifying Therapeutic Discovery Project ("QTDP"). This program was created under the Patient Protection and...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'karpos', fruit.
Related